Compounds > isoleucine

isoleucine and HIV Coinfection

isoleucine has been researched along with HIV Coinfection in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's5 (71.43)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clary, G; Longo, FM; Meeker, RB; Poulton, W; Schriver, M1
Grimwood, A; Hayes, VM; Laten, A; Petersen, DC; Rensburg, EJ; Zeier, MD1
de Ana, AM; del Real, G; Hernanz-Falcón, P; Lucas, P; Martínez-A, C; Mellado, M; Prieto, I; Rodríguez-Frade, JM; Serrano, A; Soriano, SF; Vila-Coro, AJ1
Tuma, RS1
Antinori, A; Bertoli, A; Ceccherini-Silberstein, F; Forbici, F; Liuzzi, G; Lorenzini, P; Marconi, P; Mosti, S; Narciso, P; Perno, CF; Tozzi, V; Trotta, MP; Zaccarelli, M1
de Ana, AM; Martínez-A, C; Mellado, M; Rodríguez-Frade, JM; Vila-Coro, AJ1
Agut, H; Angleraud, F; Calvez, V; Delaugerre, C; Huraux, JM; Katlama, C; Mouroux, M; Simon, A; Yvon-Groussin, A1

Other Studies

7 other study(ies) available for isoleucine and HIV Coinfection

ArticleYear
Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis.
    Experimental neurology, 2016, Volume: 275 Pt 1

    Topics: Animals; Brain; Calcium; Cell Death; Cells, Cultured; HIV Envelope Protein gp120; HIV Infections; Humans; Isoleucine; Leukocytes, Mononuclear; Macrophages; Microglia; Mitochondria; Morpholines; Neurons; Rats; Rats, Long-Evans; Receptor, Nerve Growth Factor

2016
Novel mutations and SNPs identified in CCR2 using a new comprehensive denaturing gradient gel electrophoresis assay.
    Human mutation, 2002, Volume: 20, Issue:4

    Topics: Amino Acid Substitution; Cohort Studies; Electrophoresis, Polyacrylamide Gel; Female; Genetic Predisposition to Disease; Genetic Variation; HIV Infections; HIV Seronegativity; HIV Seropositivity; HIV-1; Humans; Isoleucine; Male; Mutation; Nucleic Acid Denaturation; Polymorphism, Single Nucleotide; Receptors, CCR2; Receptors, Chemokine; Valine

2002
Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor.
    The EMBO journal, 2004, Jan-14, Volume: 23, Issue:1

    Topics: Amino Acid Substitution; Antibodies, Monoclonal; Blotting, Western; Calcium; Cell Line; Chemokine CCL2; Chemokines, CC; Chemotaxis; Culture Media, Serum-Free; Dimerization; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Flow Cytometry; Genes, Reporter; HIV Infections; HIV-1; Humans; Isoleucine; Kinetics; Ligands; Monocytes; Precipitin Tests; Receptors, CCR5; Receptors, Chemokine; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction

2004
With targeted drugs, chronic myelogenous leukemia therapy may follow HIV's model.
    Journal of the National Cancer Institute, 2007, Feb-07, Volume: 99, Issue:3

    Topics: Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Benzamides; Dasatinib; Drug Administration Schedule; Drug Costs; Fusion Proteins, bcr-abl; HIV Infections; Humans; Imatinib Mesylate; Isoleucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Threonine; United States

2007
The V118I mutation as a marker of advanced HIV infection and disease progression.
    Antiviral therapy, 2007, Volume: 12, Issue:2

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cross-Sectional Studies; Disease Progression; Drug Resistance, Multiple, Viral; Female; Follow-Up Studies; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Isoleucine; Logistic Models; Male; Mutation; Prognosis; Proportional Hazards Models; Reverse Transcriptase Inhibitors; Risk Assessment; RNA, Viral; Severity of Illness Index; Time Factors; Treatment Failure; Valine

2007
Chemokine control of HIV-1 infection.
    Nature, 1999, Aug-19, Volume: 400, Issue:6746

    Topics: Acquired Immunodeficiency Syndrome; Cell Line; Chemokine CCL2; Chemokine CXCL12; Chemokines, CXC; Dimerization; Disease Progression; HIV Infections; HIV-1; Humans; Isoleucine; Point Mutation; Receptors, CCR2; Receptors, CCR5; Receptors, Chemokine; Receptors, CXCR4; Receptors, Cytokine; Valine

1999
Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:3

    Topics: Alanine; Amino Acid Substitution; Anti-HIV Agents; Aspartic Acid; Drug Resistance, Microbial; Gene Frequency; Glutamic Acid; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Isoleucine; Mutation; Valine

2001